Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis

被引：0
|
作者：
Yunzhen Chen
Haichun Liu
Wenliang Wu
Yi Li
Jianmin Li
机构：
[1] Qilu Hospital of Shandong University,Department of Orthopedic
来源：
Journal of Experimental & Clinical Cancer Research | / 32卷
关键词：
Osteopontin; Non-small-cell lung cancer; Genetic variants; Bone metastasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Spine Metastasis Is Associated with the Development of Brain Metastasis in Non-Small-Cell Lung Cancer Patients
    Cha, Hyung-Keun
    Ryu, Woo-Kyung
    Lee, Ha-Young
    Kim, Hyun-Jung
    Ryu, Jeong-Seon
    Lim, Jun-Hyeok
    [J]. MEDICINA-LITHUANIA, 2024, 60 (01):
  • [12] Nutritional Risk Status Predicts Overall Survival of Mexican Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Campos-Gomez, S.
    Valdez-Andrade, J. J.
    Esquivel-Gutierrez, J.
    Jaimes Alpizar, E.
    Pacheco-Cuellar, G.
    Campos-Gomez, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S291 - S291
  • [13] Surrogate end points for overall survival in patients with advanced non-small-cell lung cancer in trials of immunotherapy.
    Ou, Qiyun
    Yu, Yunfang
    Li, Anlin
    Chen, Yongjian
    Wang, Ying
    Ren, Wei
    Li, Chenchen
    Yao, Herui
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [14] Role of time to progression as a surrogate marker for overall survival in patients with advanced non-small-cell lung cancer (NSCLC)
    Hotta, K.
    Kiura, K.
    Fujiwara, Y.
    Takigawa, N.
    Tabata, M.
    Ueoka, H.
    Tanimoto, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [15] Evaluating the Impact of Bevacizumab Maintenance Therapy on Overall Survival in Advanced Non-Small-Cell Lung Cancer
    Dranitsaris, George
    Beegle, Nancy
    Ravelo, Arliene
    Kalberer, Traci
    Yu, Elaine
    Thomas, Sachdev
    [J]. CLINICAL LUNG CANCER, 2013, 14 (02) : 120 - 127
  • [16] Modeling Tumor Dynamics and Overall Survival in Advanced Non-Small-Cell Lung Cancer Treated with Erlotinib
    Suleiman, Ahmed Abbas
    Frechen, Sebastian
    Scheffler, Matthias
    Zander, Thomas
    Kahraman, Deniz
    Kobe, Carsten
    Wolf, JRgen
    Nogova, Lucia
    Fuhr, Uwe
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (01) : 84 - 92
  • [17] Time trends in overall survival (OS) gain in advanced non-small-cell lung cancer (NSCLC).
    Saad, Everardo D.
    Buyse, Marc E.
    Jassem, Jacek
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [18] Overall survival should be the primary endpoint in clinical trials for advanced non-small-cell lung cancer
    Cheema, P. K.
    Burkes, R. L.
    [J]. CURRENT ONCOLOGY, 2013, 20 (02) : E150 - E160
  • [19] Different genetic profiles contribute to worse overall survival in patients with leptomeningeal metastases of non-small-cell lung cancer
    Tang, Xusheng
    Hu, Xiaojuan
    Yuan, Lin
    Yang, Hainan
    Luo, Yunfen
    Liu, Da
    Hu, Qingjun
    Shan, Changguo
    Lin, Tao
    Cai, Linbo
    Zhou, Zhaoming
    Jin, Xin
    Lei, Ming
    Hong, Weiping
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2024,
  • [20] Sarcopenia Is Associated With Worse Overall Survival in Patients With Locally Advanced Non-Small Cell Lung Cancer
    Grendarova, P.
    Arora, R.
    Bebb, G. D.
    D'Silva, A.
    Banerjee, R. N.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S201 - S202
12345